Cochrane’s Central Editorial Service has been instrumental in the Cochrane’s COVID-19 response, managing the editorial process for the following published reviews:
2021
- SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 (2 September 2021)
- Systemic corticosteroids for the treatment of COVID‐19 (16 August 2021)
- Remdesivir for the treatment of COVID‐19 (5 August 2021)
- Vitamin D supplementation for the treatment of COVID‐19: a living systematic review (25 May 2021)
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review (first updated 10 July 2020; second update 10 October 2020; third update 20 May 2021)
- International travel-related control measures to contain the COVID-19 pandemic: a rapid review (first published 16 September 2020, first updated 25 March 2021)
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (first published 26 August 2020, first updated 24 March 2021)
- Interleukin (IL)-6 blocking agents for the treatment of COVID-19. A living systematic review (18 March 2021)
- Thoracic imaging tests for the diagnosis of COVID-19 (first published 30 September 2020, first updated 26 November 2020, second update 16 March 2021)
- Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 (first published 7 July 2020, first updated 23 February 2021)
2020
- Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review (21 December 2020)
- Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review (17 December 2020)
- Thoracic imaging tests for the diagnosis of COVID-19 (26 November 2020)
- Routine laboratory testing to determine if a patient has COVID-19 (19 November 2020)
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review (first updated 10 July 2020; second update 10 October 2020)
- Interventions to support the resilience and mental health of frontline health and social care professionals during a disease outbreak, epidemic or pandemic and following de-escalation (5 November 2020)
- Prophylactic anticoagulants for people hospitalised with COVID‐19 (2 October 2020)
- Thoracic imaging tests for the diagnosis of COVID‐19 (first published 30 September 2020, first update 26 November 2020)
- Travel-related control measures to contain the COVID-19 pandemic: a rapid review (16 September 2020)
- Universal screening for people with COVID-19: a rapid review (15 September 2020)
- Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review (first published 8 April 2020; updated 14 September 2020; see also Cochrane Clinical Answers)
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (26 August 2020)
- Digital contact tracing technologies in epidemics: a rapid review (18 August 2020)
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review (first published 14 May 2020; updated 10 July 2020) (see also: Cochrane Clinical Answer)
- Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease (7 July 2020) (see also: podcast and Cochrane Clinical Answer)
- Antibody tests for identification of current and past infection with SARS-CoV-2 (25 June 2020)
- Video calls for reducing social isolation and loneliness in older people: a rapid review (22 May 2020) (see also: podcast and Cochrane Clinical Answer)
- Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review (28 April 2020) (see also: podcast and Cochrane Clinical Answer)
- Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis (21 April 2020) (see also: podcast and Cochrane Clinical Answer)
- Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff (updated 15 April 2020; further update 15 May 2020) (see also: Cochrane Clinical Answer)
- Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review (8 April 2020) (see also: podcast and three Cochrane Clinical Answers)
To submit a COVID-19 rapid review to the Central Editorial Service please editorial-service@cochrane.org for further instructions.